Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affects the skin. It is a clinically and genetically heterogeneous group of dermatological scaly skin disorders. Unfortunately, the condition has no cure.
DelveInsight, through its newsletter, brings to focus the rare genetic skin disorders present at the time of birth. Our newsletter lays down a brief introduction of the condition, its manifestations, etiology, and diagnosis.
The newsletter also focuses on treatment modalities being followed for Lamellar Ichthyosis, unmet needs prevalent in the Lamellar Ichthyosis Market, and the affected population. It also compiles happenings on the news front, Lamellar Ichthyosis emerging therapies, and international organizations supporting the affected patients, its R&D with a gist of ongoing clinical trials.
Get our newsletter directly into your email box by filling up a simple form to your right. Join our Newsletter series and get rich insights delivered every week to you
Want to explore more? Visit our infographics section for latest updates on Lamellar Ichthyosis treatment landscape
Know more about What's covered:
- Indication overview
- Epidemiological trends
- Treatment approaches
- Pipeline drugs
- Key Companies
- R&D in the field